The variation of macrophage functions suggests the involvement of multiple signalling pathways in fine tuning their differentiation. Macrophages that originate from monocytes in the blood migrate to tissue in response to homeostatic or 'danger' signals and undergo substantial morphological and functional modifications to meet the needs of the dominant signals in the microenvironment. Wnts are secreted glycoproteins that play a significant role in organ and cell differentiation, yet their impact on monocyte differentiation is not clear. In this study, we assessed the role of Wnt1 and Wnt7a on the differentiation of monocytes and the subsequent phenotype and function of monocyte-derived macrophages (MDMs). We show that Wnt7a decreased the expression of CD14, CD11b, CD163 and CD206, whereas Wnt1 had no effect. The Wnt7a effect on CD11b was also observed in the brain and spleen of Wnt7a À/À adult brain mouse tissue and in embryonic Wnt7a À/À tissue. Wnt7a reduced the phagocytic capacity of M-MDMs, decreased interleukin-10 (IL-10) and IL-12 secretion and increased IL-6 secretion. Collectively, these findings demonstrate that Wnt7a generates an MDM phenotype with both pro-inflammatory and alternative MDM cytokine profiles and reduced phagocytic capacity. As such, Wnt7a can have a significant impact on macrophage responses in health and disease.
Introduction
Macrophages exists as a continuum of subtypes, each with its own unique function including phagocytosis, antigen processing and presentation, and release of tissue remodelling factors, homeostatic proteins, and pro-and anti-inflammatory cytokines. Due to their importance in health and disease, understanding the signals that regulate macrophage differentiation and phenotype is paramount to gaining a better understanding of their functions as well as revealing potential therapeutic targets. Circulating blood monocytes differentiate into specific macrophage phenotypes depending on the signals they receive. 1, 2 Macrophage colony-stimulating factor (M-CSF) with lipopolysaccharide (LPS) and interferon-c (IFN-c) induce monocytes to differentiate into M-1 (pro-inflammatory) like-monocyte-derived macrophage (MDMs). M-CSF with the addition of interleukin-4 (IL-4), IL-10, or transforming growth factor-b generates an alternative/regulatory-like macrophage phenotype (M2-MDMs). M2a-MDMs, differentiated in the presence of IL-4, exhibit increased expression of scavenger receptors, CD163 and CD206, and have increased phagocytic capacity. 3, 4 Other morphogens can skew the differentiation of monocytes, impacting their function in tissue. In particular, emerging data point to the impact of Wnts on monocyte differentiation; specifically, Wnt5a expression is associated with monocyte-derived dendritic cells, and in haematopoietic cells there are more monocyte or pro-monocyte cells in the presence of either Wnt5a or Wnt11, and the appearance of macrophages was inhibited. 5, 6 Wnts are ubiquitously expressed proteins that guide cell fate, development and differentiation in utero and a growing body of evidence points to their importance in cell differentiation and function post-development. [7] [8] [9] [10] [11] [12] [13] [14] [15] Wnts are a family of 19 evolutionary conserved. They bind to a seven transmembrane Frizzled receptor and one of various coreceptors -culminating in either a b-catenin-dependent (canonical) or independent (non-canonical: i.e. Planar Cell Polarity or Ca 2+ /Calmodulin) signalling pathway. Historically, Wnts (1, 2, 2b, 3, 3a, 4, 5a, 5b, 6, 7a, 7b, 8a, 8b, 9a, 9b, 10a, 10b, 11 and 16) were categorized on the basis of whether they induce b-catenin-dependent or bcatenin-independent signalling; however, there is an increasing recognition that this classification is no longer accurate. Wnts, depending on interaction with frizzled receptors, can mediate either pathway. For example, Wnt5a, classically, signals through the non-canonical/bcatenin-independent pathway. 16 However, by binding to Frizzled 4 and the LRP5 co-receptor, Wnt5a engages the canonical/b-catenin-dependent pathway. 16 These studies underscore an emerging paradigm of Wnt signalling, whereby the context of Wnt receptors dictates canonical versus non-canonical Wnt pathways. 16, 17 We focused here on evaluating the role of Wnt1 and Wnt7a in regulating monocyte differentiation, both phenotypically and functionally. Both Wnts engage the canonical b-catenin signalling pathway, whereby they bind to Frizzled receptors and LRP5/6 to induce a signalling cascade that inactivates glycogen synthetase kinase-3b to stabilize b-catenin. b-Catenin in turn translocates to the nucleus where it binds to the T-cell factor/lymphoid enhancer factor (TCF/LEF) family of transcription factors to regulate gene expression. Although Wnt1 predominantly induces canonical b-catenin signalling, Wnt7a can also activate the AKT/mammalian target of rapamycin (AKT/mTOR) pathway, albeit in skeletal muscles, 18 and peroxisome proliferator-activated receptor c (PPARc) via activation of extracellular signal-regulated kinase 5 (ERK5). 19 Wnt7a is expressed by stromal epithelial cells; 20 it is required for the development of the blood-brain barrier [21] [22] [23] and has also been observed to induce tumoursuppressive cellular senescence in the lung. 24 Notably, macrophages within tumours are known regulators of tumour progression, as signals from the tumour microenvironment regulate the macrophage phenotype, which in turn regulates the phenotype and function of infiltrating immune cells. 25, 26 Therefore, the effect of Wnt7a on lung cancer progression may be through its influence on macrophage phenotype. As such, due to the ability of Wnt7a to activate more than one signalling pathway that potentially influences cell phenotype and function, as well as its effect on blood-brain barrier development and lung cancer pathogenesis, we hypothesize that Wnt7a may be important in the differentiation of monocytes to MDMs in the brain and other tissue. Relative to Wnt7a, the influence of Wnt1 on various cell types and disease processes has been more widely described; where in macrophages, Wnt1 induces CD36 expression 27 and prevents apoptosis in microglia. 28 We report here that activated monocytes down-regulate Wnt7a expression and that Wnt7a, but not Wnt1, significantly inhibited the expression of CD14, CD11b, CD163 and CD206 on MDMs. The aforementioned proteins are classical markers associated with myeloid cell phenotype and function, specifically; CD14 is a pathogen recognition receptor (PRR) found on human monocytes and macrophages. 29 CD11b is the a subunit of the integrin heterodimer CR3 or Mac-1; known functions include cellular migration, 30 phagocytosis, 31 and cellular activation. 
Materials and methods

Ethics statement
Research involving human subjects was conducted in accordance with institutional (IRBL06080703) and U.S. Government guidelines on human research.
Animal care
Animal experiments were conducted in accordance with the recommendations in the Guide for the Care sterile, we made use of heterozygotes for colony maintenance. The genetic background of the mice was determined using PCR of DNA from tail biopsies. For embryos; after removing a limb for genotyping, the embryos were briefly fixed in 2% paraformaldehyde in PBS before being embedded in optimal cutting temperature compound (OCT) and snap frozen. Adult mice were killed using CO 2 and perfused with PBS, before removal of brain and spleen. Half of the adult brain was fixed overnight in 2% paraformaldehyde followed by 30% sucrose and fixed in OCT blocks before cryosectioning. Mouse spleens were crushed and incubated with red blood cell lysis buffer (Clontech Laboratories, Mountain View, CA) before cell culture experiments.
Generation of monocyte-derived macrophages
Monocyte populations were enriched directly from healthy human whole blood by negative immune-selection (STEMCELL Technologies, Vancouver, BC, Canada). Approximately 0Á5 9 10 6 cells/ml were cultured in RPMI-1640 supplemented with 10% fetal bovine serum (FBS) for 7 days in the presence of 50 ng/ml M-CSF (R&D Systems, Minneapolis, MN). To obtain M1-like and M2-like MDM cells, 50 ng/ml IFN-c (R&D Systems) and 1 lg/ml LPS (Sigma-Aldrich, St Louis, MO, USA) or 10 ng/ml IL-4 (R&D Systems), respectively, were added. Experimental groups were treated with 50 ng/ml M-CSF in addition to 300 ng/ml of either Wnt1 or Wnt7a (Abcam, Cambridge, UK) active full-length human recombinant proteins. Growth factors, cytokines and Wnt proteins were added every other day, whereas IL-4 was added during the last 48 hr of the experiment, IFN-c was added 48 hr before, followed by stimulation with LPS 24 hr before ending the experiment. Mouse MDMs were obtained by culturing splenocytes overnight in complete macrophage medium. Briefly, complete macrophage medium consisted of Dulbecco's modified Eagle's medium with high glucose and pyridoxine hydrochloride (Gibco, Waltham, MA), heatinactived fetal calf serum, modified Eagle's medium essential amino acids (Gibco), L-glutamine (Gibco), HEPES buffer (Gibco), penicillin and streptomycin, and 50 mM 2-mercaptoethanl. After overnight activation and adherence of monocytes, suspension cells were removed and adherent cells were washed twice with Dulbecco's PBS (Corning, Manassas, VA) before replacing complete macrophage medium. Cells were cultured for 7 days followed by overnight incubation with Wnt7a and subsequent flow cytometric analysis.
Multiplex assay
Secretion of IL-6, IL-1b, IL-10, IL-12p70 and tumour necrosis factor-a (TNF-a) from differentiated MDMs were measured with a human cytokine magnetic 5-Plex Panel (EMD Millipore, St Louis, MO) according to the manufacturer's protocol.
Phagocytosis assay
Phagocytosis was assessed on 7-day differentiated MDMs using pHrodo Staphylococcus aureus bioparticles (Life Technologies, Carlsbad, CA) following the manufacturer's protocol scaled to a 12-well format. Briefly, differentiated macrophages were cultured with pHrodo S. aureus bioparticles for 90 min, washed with PBS and fluorescence signal was assessed by microscopy and by flow cytometry to calculate median fluorescence intensity to identify phagocytic cells.
Flow cytometry
Differentiated macrophages were assessed by flow cytometry for extracellular markers: lineage marker CD3/CD19/ CD20/CD56 (allophycocyanin; Biolegend, San Diego, CA), CD14 (BV786; Biolegend), CD16 (Peridinin chlorophyll protein-Cy7; BD Biosciences, San Jose, CA), CD11b (allophycocyanin-Cy7; BD Biosciences), HLA-DR (Peridinin chlorophyll protein; BD Biosciences), CD163 (PeTexas Red, BD Biosciences) and CD206 (phycoerythrin, FITC; BD Biosciences). Data were collected on the BD Fortessa Flow Cytometer with BD FACS DIVA software (BD Biosciences) and analysed using FLOW JO FLOW Analysis Software (Treestar Inc., Ashland, OR).
Immunofluorescence
Mouse embryos and adult brain cryosections (20 lm) from Wnt7a À/À and WT mice were stained with F4/80
(1 : 100, anti-rabbit Cy3; Abcam), CD11b (1 : 100, antirat AF647; Abcam), isolectin b4 (1 : 100, AF488; Life Technologies), and DAPI (Molecular Probes, Eugene, OR) and visualized using an LSM 710 or LSM 700 confocal microscope (Carl Zeiss, Oberkochen, Germany).
Quantitative real-time RT-PCR
Total RNA was extracted using the RNeasy mini prep kit (Qiagen, Hilden, Germany), followed by incubation with DNase (Sigma-Aldrich) and retrotranscription (cDNA qScript; Quantabio, Beverly, MA). Quantitative real-time RT-PCR was performed using Ssofast Evagreen Supermix ). Primers were designed using IDTDNA (San Diego, CA) PRIMERQUEST design software. They are: Wnt1 Forward GAA CGC TCT CTT CCA GTT CTC, Wnt1 Reverse GGA GAG ATG GAT CGC TAT GAA C; Wnt2 
Statistical analyses
When the data were distributed normally, analysis of variance and post-hoc tests were used. When the data were not normally distributed, non-parametric analysis was performed. All tests assumed a two-sided significance level of 0Á05 using GRAPHPAD INSTAT 3 Software (San Diego, CA) for data analysis.
Results
Wnt7a mRNA expression decreases after monocyte activation
We evaluated mRNA expression of the 19 Wnts 24 hr after monocytes were cultured in the presence of M-CSF (Table 1) . At 24 hr, both Wnt2 and Wnt7a were significantly decreased, whereas the expression of Wnt1 and Wnt5a was significantly increased in comparison to freshly isolated monocytes. These data suggest that Wnts are differentially expressed upon monocyte activation at the early stages of differentiation.
Wnt7a inhibits the expression of CD14, CD11b, CD163 and CD206
Isolation of monocytes, flow cytometry gating strategy/ culture purity, generation of MDM, M1-MDMs and M2a-MDMs, and the treatment paradigm with Wnt1 or Wnt7a are described in the Supplementary material (Fig. S1) . MDM, M1-MDMs or M2a-MDMs were treated with either Wnt1 or Wnt7a and expression of CD14, CD11b, CD163 and CD206 was evaluated by flow cytometry. CD14 and CD11b expression distinguish macrophages from other cell types. These proteins are involved in response to microbial products, adhesion and migration, and are therefore important for macrophage function. 35, 36 CD163 and CD206 are scavenger and mannose receptors, respectively, often associated with alternative macrophage phenotypes and phagocytic function. (Fig. 1a) . Wnt7a also significantly inhibited the expression of CD11b on M-MDM, M1-MDM and M2a-MDM (Fig. 1b) and reduced CD163 expression on M1-MDM (P < 0Á05), but not on M-MDMs or M2a-MDMs (Fig. 1c) . Wnt7a reduced CD206 expression on both M-MDM and M1-MDM cells (P < 0Á05) but not on M2a- MDMs (Fig. 1d) . The M2a-MDM control expressed higher levels of CD163 and CD206 relative to the M-MDM and M1-MDM controls and Wnt7a addition to M2a-MDMs did not decrease CD163 or CD206 expression (data not shown). Wnt5a, which was enhanced at the transcriptional level after monocyte activation (Table 1) , did not show significant effects on these surface markers and as such was excluded from further analysis (data not shown). These data demonstrate that Wnt7a inhibits the expression of classical markers of macrophage differentiation and polarization in MDMs differentiated in vitro.
Wnt7a
À/À mice express higher levels of CD11b
To assess whether these in vitro observations translate to in vivo conditions, we assessed CD11b and F4/80 (a mouse macrophage marker) expression on Wnt7a (Fig. 2b) as well as significantly higher median fluorescence intensity (Fig. 2c) (Fig. 2d ). These data demonstrate that Wnt7a down-regulates CD11b expression on monocytes both in vitro and in vivo.
Wnt7a inhibits phagocytosis
Given that Wnt7a reduced the expression of two molecules associated with macrophage phagocytic capability, CD11b and CD206, we assessed the impact of Wnt7a on MDM phagocytic function. MDMs, after in vitro differentiation, were incubated with pHrodo S. aureus bioparticles for 90 min. M-MDMs differentiated in the presence of Wnt7a showed a significantly reduced ability to take up foreign particles (Fig. 3a,b ). Wnt1 or Wnt7a had no significant effect on the phagocytic capacity of M1-MDMs or M2a-MDMs. These data demonstrate that Wnt7a reduces the phagocytic potential of M-MDM.
Wnt7a influences the cytokine profile of MDMs
To assess the impact of Wnt7a on cytokine secretion of MDMs, we collected cell culture supernatant of fully differentiated cells for analysis with a human cytokine magnetic 5-Plex Panel for the Luminex TM for IL-1b, TNF-a, IL-10, IL-6 and IL-12p70. In the presence of Wnt7a, there was a decrease in IL-10 relative to the M-MDM and M2a-MDM controls (p < 0Á05), but not relative to the M1-MDM control (Fig. 4a) . There was also a reduction in IL-12p70 in the presence of Wnt7a, but not Wnt1, in the M1-MDM control, and IL-12p70 was undetectable in M-MDM and M2a-MDMs (Fig. 4b) . Interleukin-6 secretion was significantly increased in the presence of Wnt7a relative to all MDM controls (Fig. 4c) . Neither IL-1b nor TNF-a levels were significantly altered by Wnt7a (Fig. 4d,  e ). These data demonstrate that Wnt7a influences cytokine secretion from MDMs, particularly in a manner that does not promote classical polarization of cytokine responses associated with M1 or M2 phenotypes.
Discussion
Monocyte-derived macrophages are exceptionally plastic, a trait that allows them to alter their function to meet the requirements of their microenvironment. Therefore, it is important to define physiologically relevant factors that fine-tune MDM phenotype and function, including their rate of development, the proteins they secrete, and the receptors they express. While skewing of monocytes to M-1 or M2a-MDM phenotypes is well characterized in response to classical stimulation (e.g. M-CSF/LPS/IFN-c or M-CSF+IL-4/IL-10/or transforming growth factor b, respectively), little is known about the role of Wnts in skewing monocyte differentiation.
To date, the role of Wnt3a and Wnt5a has been evaluated in the context of macrophage functions. Wnt5a through CamMK11 signalling induced inflammatory cytokines of macrophages 38 and it was also reported to induce immunosuppressive macrophages. 39 These rather dichotomous reports may be context dependent. Further, Wnt5a was reported to stimulate phagocytosis, although this was based on mouse macrophage studies rather than human macrophages. 40 Wnt3a also induced pro-inflammatory cytokines by mouse macrophages, but led to sensitization of macrophage responses to subsequent Tolllike receptor 2 and 9 stimulation. 41 We show here that Wnt7a induces monocytes to differentiate towards a unique MDM phenotype with both M1-like and alternative-like MDM properties. As such, levels of Wnt7a in various tissues can significantly alter monocyte differentiation, regulating the phenotype and function of MDMs.
Specifically, we show that activated monocytes down-regulate Wnt7a expression and that Wnt7a but not Wnt1 significantly inhibited the expression of CD14, CD11b, CD163 and CD206 on MDMs. For CD11b, this inhibition was also observed in vivo in a Wnt7a
À/À mouse model. Wnt7a also inhibited phagocytic capacity of MDMs, which is probably due to Wnt7a-mediated down-regulation of CD206 and CD11b, two molecules associated with phagocytosis. 37, 42 Wnt7a inhibited the secretion of IL-10 from alternative MDM controls and inhibited the secretion of IL-12 from M1-like MDM controls. Conversely, IL-6 secretion was significantly increased relative to all MDM controls as well as MDMs differentiated in the presence of Wnt1. IL-6 has been shown to skew MDMs toward an alternative phenotype; 43, 44 however, IL-6 is notoriously pleiotropic and needs to be assessed in combination with other factors to determine its role in each context. In this case, cells primed with IFN-c and stimulated with LPS secreted significantly higher amounts of IL-6 than cells that were differentiated in just M-CSF or M-CSF with IL-4. The cells that secreted more IL-6 also down-regulated CD206 and CD163 expression and had significantly higher expression of IL-12p70, TNF-a and IL-1b relative to the M-CSF and alternative controls. The significant decrease in IL-12p70 expression as well as the limited effect on IL1b and TNF-a suggests that the Wnt7a MDMs may not be completely pro-inflammatory. Further, Wnt7a-mediated down-regulation of IL-12p70 and IL-10 simultaneously underscores the heterogeneity of MDMs in vivo to display both pro-and anti-inflammatory characteristics simultaneously. 45, 46 The finding that Wnt7a skews monocyte differentiation is particularly relevant to HIV invasion in the central nervous system. HIV invades the central nervous system within weeks of infection through both trafficking of T cells and also monocytes that harbour HIV DNA, yet are not productively infected unless they differentiate into macrophages. 47 Studies from our laboratory demonstrated that robust b-catenin is expressed in monocytes and blocks active HIV transcription, yet as these monocytes differentiate into macrophages they support productive infection. As such, Wnt7a secreted by endothelial cells and neurons [48] [49] [50] [51] can potentially regulate monocyte differentiation in the brain, as the data suggest, in a way that may inhibit their differentiation, and subsequent susceptibility to HIV infection. Further, Wnt7a-responsive macrophages are likely to be less phagocytic and as such may not contribute significantly to controlling neuroinflammation by way of clearing debris and dying cells that can perpetuate inflammation. However, because microglia and astrocytes have both demonstrated phagocytic capacity, [52] [53] [54] it remains to be seen whether Wnt7a-mediated reduction in phagocytic capacity has a significant impact on neuroinflammation. These findings underscore the complexity of monocyte/macrophage differentiation in response to a variety of morphogens and highlight the complexity of these responses as context dependent and not necessarily as just M-1 and M-2 like macrophages. Indeed, Wnt7a, and similar physiological signals, may serve to regulate inflammatory responses, resulting in reduced cell damage that can occur from chronic inflammation. Simultaneous reduction in IL-10 also suggests that Wnt7a-MDM may not inhibit the response of other immune cells, but rather serves as a regulator that modulates excessive inflammatory or anti-inflammatory responses. An intermediate MDM phenotype may be favourable in disease and homeostasis; in neuroAIDS inflammatory M1 macrophages perpetuate neuroinflammation, 55 whereas alternative macrophage phenotypes are a marker of a worsened prognosis due to the inability of macrophages to promote anti-viral CD8 + T-cell responses. 56 Additionally, macrophages inhibit would healing, 57, 58 while anti-inflammatory macrophages are notorious allies in tumour development through their ability to inhibit anti-tumour responses from other immune cells. 59 Future experiments should assess the relevance of Wnt7a on MDM function in neuroAIDS by gain and loss of function studies using in vitro and in vivo Wnt7a knockout and over-expression models. Ultimately, understanding how monocyte/macrophages respond to signals in their microenvironment, particularly from proteins such as Wnts that demonstrated ubiquitous expression and ability to influence cell fate and function, can serve as novel approaches to regulate immune responses in particular diseases and/or tissues. 
